Cargando…

Molecular Characterization and Treatment Approaches for Pediatric H3 K27-Altered Diffuse Midline Glioma: Integrated Systematic Review of Individual Clinical Trial Participant Data

SIMPLE SUMMARY: Diffuse midline glioma, H3 K27-altered are central nervous system tumors that primarily affect the pediatric population. Currently, there are no curative therapies, with several completed and on-going clinical trials exploring many different therapeutic options. In this systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damodharan, Sudarshawn, Abbott, Alexandra, Kellar, Kaitlyn, Zhao, Qianqian, Dey, Mahua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340772/ https://www.ncbi.nlm.nih.gov/pubmed/37444588 http://dx.doi.org/10.3390/cancers15133478

Ejemplares similares

BIOL-19. DIFFUSE MIDLINE GLIOMA CEREBRAL ORGANOID MODEL AND MULTIOMICS CHARACTERIZATION
por: Damodharan, Sudarshawn, et al.
Publicado: (2023)

Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials
por: Damodharan, Sudarshawn, et al.
Publicado: (2022)

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
por: Zhao, Ji-ping, et al.
Publicado: (2022)

Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma
por: Miguel Llordes, Gloria, et al.
Publicado: (2023)

DIPG-42. Diffuse midline gliomas, H3K27-altered as an interdisciplinary challenge
por: Kammler, Gertrud, et al.
Publicado: (2022)

Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration
por: Huang, Bowen, et al.
Publicado: (2023)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

DIPG-44. H3K27-altered diffuse midline gliomas with secondary driver molecular alterations
por: Gestrich, Catherine, et al.
Publicado: (2022)

Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient
por: Cheng, Ran, et al.
Publicado: (2021)

Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review
por: De Martino, Lucia, et al.
Publicado: (2023)

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

Fatal Postpartum Hemorrhage in Diffuse Midline Glioma with H3-K27M Mutation
por: Miyazaki, Takeshi, et al.
Publicado: (2019)

Radiotherapy and radio‐sensitization in H3 (K27M) ‐mutated diffuse midline gliomas
por: Liu, Chao, et al.
Publicado: (2023)

A H3K27M-targeted vaccine in adults with diffuse midline glioma
por: Grassl, Niklas, et al.
Publicado: (2023)

Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma
por: Hohm, Annika, et al.
Publicado: (2021)

Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations
por: Damodharan, Sudarshawn, et al.
Publicado: (2023)

Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas
por: Raab, Peter, et al.
Publicado: (2022)

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
por: Wingerter, Arthur, et al.
Publicado: (2021)

Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

Case Report: Five Adult Cases of H3K27-Altered Diffuse Midline Glioma in the Spinal Cord
por: Gu, Quanquan, et al.
Publicado: (2021)

DIPG-51. ABDOMINAL METASTASES OF DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED WITH A VENTRICULOPERITONEAL SHUNT
por: Lazow, Margot, et al.
Publicado: (2023)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
por: Banan, Rouzbeh, et al.
Publicado: (2017)

Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas
por: Welby, John P., et al.
Publicado: (2019)

Morphological Spectrum and Survival Analysis of Diffuse Midline Glioma With H3K27M Mutation
por: Hassan, Usman, et al.
Publicado: (2021)

Diffuse midline glioma H3K27M mutation in adult: A case report
por: Bhattarai, Ayush Mohan, et al.
Publicado: (2022)

Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman
por: Low, Justin Thomas, et al.
Publicado: (2021)

DIPG-53. LSD1 DEGRADATION SYNERGIZES WITH HDAC INHIBITION IN PEDIATRIC H3K27M DIFFUSE MIDLINE GLIOMA
por: Haase, Rebecca, et al.
Publicado: (2023)

Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time
por: Power, Erica A, et al.
Publicado: (2023)

Diffuse midline glioma, H3K27-altered, of the conus medullaris presenting as acute urinary retention: illustrative case
por: Saluja, Sabir, et al.
Publicado: (2023)

CEREBELLAR DIFFUSE MIDLINE GLIOMA, H3K27M ALTERED IN A FIFTY-FIVE-YEAR-OLD PATIENT
por: Ibdah, Haleem, et al.
Publicado: (2023)

Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type
por: Vallero, Stefano Gabriele, et al.
Publicado: (2023)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020)

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
por: Majzner, Robbie G., et al.
Publicado: (2022)

A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
por: Peng, Youheng, et al.
Publicado: (2023)

Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures
por: Banan, Rouzbeh, et al.
Publicado: (2021)

Radio-Resistance and DNA Repair in Pediatric Diffuse Midline Gliomas
por: Pedersen, Henriette, et al.
Publicado: (2020)

Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation
por: El Malki, Khalifa, et al.
Publicado: (2023)

The promise of metabolic imaging in diffuse midline glioma
por: Lovibond, Samantha, et al.
Publicado: (2023)

A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis
por: Aftahy, A. Kaywan, et al.
Publicado: (2023)

Deep learning‐based prediction of H3K27M alteration in diffuse midline gliomas based on whole‐brain MRI
por: Huang, Bowen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_biour1fq77bg516grgj4m61v4m